MSD is a global research-based pharmaceutical company with a 125-year history with locations in over 140 countries and 69,000 employees. The head office is located in Kenilworth, NJ, USA.
In Sweden, MSD has 140 employees. The affiliate markets drugs and vaccines and carries out clinical trials.
Contact
Merck Sharp & Dohme (Sweden) AB
Gävlegatan 22
113 30 Stockholm, Sweden
Tel: +46 8 – 578 135 00
Thanks to the cooperation of its citizens, Sweden boasts a comprehensive patient registry of electronic health records. Multinational pharma companies increasingly look to these registries to collect real-world evidence, which…
Grifols is a pioneer in plasma science that develops plasma into essential medicines used to treat rare, chronic and life-threatening conditions. Eric Björnestål, general manager for the Nordic region, explains…
Patrick Van de Velde, general manager of Promega’s Swedish affiliate and also responsible for the company’s operations in Nordics, highlights the reason why Sweden has been selected as one of…
Martin Tenlen was appointed as the general manager of the Nordics region for CSL Behring, the world’s fifth-largest biotech company, at the start of 2019. He highlights his priorities for…
Swedish Medtech is Sweden’s largest medical technology industry organization, representing more than 180 companies. CEO Anna Lefevre Skjöldebrand explains how patient needs are driving today’s medical device industry, analyzes Sweden’s…
Karo Pharma is a Swedish specialty pharma company that develops and markets products to pharmacies and healthcare providers. CEO Christoffer Lorenzen discusses the company’s growth strategy through acquisitions of trusted…
Berkeley Vincent, managing director of Janssen in the Nordics and Baltics, discusses the challenges of the digital future for the Swedish affiliate and the whole healthcare industry and highlights Janssen’s…
Peter Marcusson, general manager of Ferring’s Nordics affiliate, located in Malmö, the original birthplace of the company, emphasizes the renewed strategic importance of Sweden and the Nordic region for Ferring…
A relative newcomer to the Nordic countries, Otsuka has successfully built a strong foothold in the region. Pontus Billstam, managing director for the Nordics & Benelux, looks back at the…
Though far from the largest pharma market in Europe, Sweden nevertheless holds strategic importance for global pharma; from the country’s attitude to public health to its sophisticated digital framework, comprehensive…
Ascelia Pharma is a Swedish oncology start-up based in Malmö. CEO Magnus Corfitzen talks about the opportunities they have found in the orphan oncology drug market, the promising phase III…
Olav Fromm, managing director of Chiesi Nordics, explains the deep roots of Chiesi in Sweden, where its blockbuster drug, a surfactant for treating neonatal babies, was developed. He also touches…
See our Cookie Privacy Policy Here
